FSFatima Sajjad

Fatima Sajjad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fatima Sajjad has a total of 250 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Stent assisted coiling versus non-stent assisted coiling for unruptured intracranial aneurysms: a systematic review and meta-analysis for clinical and angiographic outcomes

    by Anfal Binte Amin, Fatima Yousaf, S. M. Aleem Hussain, Hamnah Binte Zafar, Muhammad Huzaifah Khattak, Fatima Sajjad, Abdul Moiz, Abdul Moez, Aleeza Khattak, Bilal Muhammad Ali, et al.

    Background: Stent-assisted coiling (SAC) has been increasingly adopted to treat unruptured intracranial aneurysms (UIAs), particularly for wide-neck aneurysms, for which conventional coiling may be technically challenging. However, its comparative safety and effectiveness relative to non-stent-assisted coiling (non-SAC) remain uncertain. This systematic review and meta-analysis evaluated the clinical and angiographic outcomes of SAC versus non-SAC in patients with UIAs. Methods: A systematic search of PubMed, Embase, and the Cochrane Library was conducted from database inception to July 30, 2025. Randomized controlled trials and observational studies comparing SAC with non-SAC in adults with UIAs were included. Two reviewers independently performed study selection, data extraction, and quality assessment. Risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using random-effects models in Review Manager 5.4. Results: Eight studies involving 7,682 patients met the inclusion criteria, including one randomized controlled trial and seven observational studies. SAC was associated with a significantly higher rate of complete aneurysm occlusion at follow-up (RR 1.19, 95% CI 1.09–1.29), while no significant differences were observed in initial complete occlusion, aneurysm recurrence, intraprocedural rupture, or hemorrhagic complications. However, SAC was associated with a significantly greater risk of ischemic events compared with non-SAC (RR 1.81, 95% CI 1.51–2.19). Overall certainty of the evidence was limited by the predominance of observational studies and the risk of bias in the single randomized trial. Conclusion: Compared with non-stent-assisted coiling, SAC improves long-term angiographic occlusion but increases the risk of ischemic complications without demonstrating clear advantages in recurrence or procedural safety. These findings support an individualized treatment approach based on aneurysm characteristics and patient-specific factors rather than routine use of SAC for all unruptured intracranial aneurysms.

  • Open Access

    Metallic versus plastic stents for the management of biliary obstruction

    by Aleena Amir Malik, Manal Sharif, Waqas Kareem, Muhammad Qaseem, Yashfa Asad, Saad Rahman, Ismail Tajudeen Hamza, Husna Khan, Abdul Qayam Khan, Fatima Sajjad, et al.

    Background: Biliary obstruction can be managed with metallic stents (MS) or plastic stents (PS), but comparative evidence across benign and malignant conditions remains uncertain. We conducted a systematic review and meta-analysis comparing MS and PS. Methods: PubMed, Embase, Scopus, Web of Science, and Cochrane CENTRAL were searched from inception to the search date. Randomized controlled trials and observational studies comparing MS with PS in patients with benign or malignant biliary obstruction were eligible. Primary analyses compared MS with PS across the overall eligible population, including both benign and malignant obstruction. Where sufficient outcome-specific data were available, subgroup analyses were performed according to disease etiology (benign vs malignant). Outcomes included functional success, adverse events, recurrent biliary obstruction (RBO), procedure time, and overall survival. Meta-analysis was performed with Hartung–Knapp sensitivity analyses. Results: Nine studies comprising 890 participants were included. Functional success was comparable between MS and PS (RR = 1.03, 95% confidence intervals [CI]: 0.96–1.11). Among 8 studies contributing adverse-event data, no significant difference was observed (RR = 1.37, 95% CI: 0.92–2.03; P = .123; I 2 = 45.4%). Adverse events were higher with MS in malignant disease (RR = 1.74, 95% CI: 1.15–2.63) but not benign disease (RR = 1.01, 95% CI: 0.83–1.23; P for subgroup difference = .020). Hartung–Knapp analysis remained non-significant (RR = 1.37, 95% CI: 0.96–1.95; P = .078). MS showed a lower risk of RBO (RR = 0.61, 95% CI: 0.32–1.17; I 2 = 93.1%), supported by Hartung–Knapp analysis (RR = 0.61, 95% CI: 0.41–0.91). Conclusion: MS and PS demonstrated comparable functional success and overall adverse-event rates, although adverse events were higher with MS in malignant disease. MS may improve stent durability, but substantial heterogeneity limits certainty. Available studies did not demonstrate a consistent survival advantage. Further randomized trials are warranted.

  • Open Access

    Post‐Dengue Deep Vein Thrombosis Complicated by Pulmonary Embolism: A Case Report

    by Sarah Nisar, Hamza Mushtaq, Muhammad Haris Khan, Fatima Sajjad, Abdullah Afridi, Noor E Fatima, Kamil Ahmad Kamil

    Dengue fever is commonly associated with bleeding complications, particularly in patients with thrombocytopenia. However, thrombotic events, such as venous thromboembolism, are rare and under‐recognized manifestations, particularly during the recovery phase, posing diagnostic and therapeutic challenges. We report the case of a 25‐year‐old previously healthy male who presented with high‐grade fever, myalgia, and headache and was diagnosed with dengue fever based on positive NS1 antigen testing. Dengue infection was confirmed by a positive NS1 antigen test performed on Day 3 of illness, consistent with early acute dengue infection. The diagnosis was further supported by the patient's clinical presentation, including high‐grade fever, myalgia, and headache in the appropriate epidemiological context of a dengue‐endemic region. During the recovery phase of the illness, he developed painful swelling of the right lower limb and progressive dyspnea. Investigations revealed markedly elevated D‐dimer levels, right lower limb deep vein thrombosis on Doppler ultrasound, and bilateral pulmonary emboli with right ventricular strain on CT pulmonary angiography images. Although dengue‐associated thrombosis has been reported in the setting of thrombocytopenia, as described by Ghatak et al., the present case demonstrates that thrombotic complications may also occur despite preserved platelet counts, highlighting the potential contribution of endothelial dysfunction and inflammatory activation. This case highlights the paradoxical coexistence of thrombosis and bleeding risk in dengue fever. To avoid potentially fatal thromboembolic complications in patients with dengue, early diagnosis, prompt anticoagulation, and a high index of suspicion are crucial.

  • Enhanced Recovery After Surgery Versus Conventional Care in Elderly Patients Undergoing Transvaginal Pelvic Floor Reconstruction: A Systematic Review and Meta-Analysis

    by Aqsa Khanzada, Syeda Vilay Zehra Rizvi, Farah Hadi, Benish Khan, Fatima Sajjad, Fazia Khattak, F. N. U. Fahad, Fatima Abid, Fatima Yousaf, Kainat Sheraz, et al.

  • Efficacy and Safety of Cisplatin Versus Carboplatin for Patients With Squamous Cell Carcinoma of Head and Neck: A Systematic Review and Meta‐Analysis

    by Samiya Rahim, Muskan Kumari, Eisha Abid, Rida Khan Hoti, Fatima Sajjad, Fatima Tu Zahra Hafeez Khan, Muskan Hotak, Salma Afridi, Ahmad Ali, Hassaan Muhammad, et al.

    Background: Cisplatin‐ and carboplatin‐based regimens are widely used in the treatment of head and neck squamous cell carcinoma (HNSCC), yet comparative evidence on survival and toxicity outcomes remains limited. While cisplatin is standard in many settings, carboplatin is often preferred in patients with comorbidities or impaired renal function. This systematic review and meta‐analysis aimed to synthesize available evidence comparing cisplatin versus carboplatin in HNSCC. Methods: A comprehensive literature search was conducted in PubMed, Embase, and the Cochrane Library from inception to February 2026. Randomized and observational studies comparing cisplatin‐ and carboplatin‐based regimens in HNSCC were included. Primary outcomes were overall survival (OS), progression‐free survival (PFS), locoregional recurrence‐free survival at 1, 3, and 5 years and distant metastasis‐free survival (DMFS) at 1 and 3 years. Secondary outcomes include grade ≥ 3 toxicities. Data were pooled using random‐effects meta‐analysis. Results: Eight studies comprising 1044 patients were included, including four recently published studies not previously pooled in head‐to‐head analyses. Pooled analyses showed no statistically significant differences between cisplatin and carboplatin in OS, PFS, LRRFS, or DMFS overall. Subgroup analyses across 1, 3, and 5‐year follow‐up intervals likewise demonstrated no significant differences for most outcomes. The only significant finding was a modest difference in 5‐year LRRFS favoring cisplatin, based on only two studies. No statistically significant differences were observed in grade ≥ 3 anemia, leukopenia, thrombocytopenia, or nausea/vomiting. Conclusions: Cisplatin and carboplatin‐based regimens yield largely comparable survival and toxicity outcomes in HNSCC. Treatment selection should be guided by patient comorbidities and tolerability.

  • Open Access

    Catheter Ablation Versus Medical Therapy in Atrial Fibrillation With Heart Failure With Reduced or Mildly Reduced Ejection Fraction: A GRADE ‐Assessed Systematic Review and Meta‐Analysis

    by Aleena Amir Malik, Nasir Saeed, Goodluck Oparaugo, Muhammad Waqar Shahid, Waqas Kareem, Fatima Yousaf, Zain Ul Abedeen, Fatima Sajjad, Kashif Yousaf, Fizza Kazmi, et al.

    Background: Catheter ablation is an established rhythm‐control strategy for atrial fibrillation (AF), but its effectiveness in patients with heart failure with reduced or mildly reduced ejection fraction (HFrEF/HFmrEF) remains incompletely defined. We performed a GRADE‐assessed systematic review and meta‐analysis comparing catheter ablation with conventional medical therapy in this population. Methods: PubMed, Embase, and the Cochrane Library were searched from inception to February 2026. Randomized controlled trials and observational cohort studies enrolling adults with AF and left ventricular ejection fraction (LVEF) ≤ 50% were included. Primary outcomes were all‐cause mortality, cardiovascular mortality, and change in LVEF. Secondary outcomes were change in B‐type natriuretic peptide (BNP) and cardiovascular hospitalization. Random‐effects models were used, and certainty of evidence was assessed using GRADE. Results: Thirteen studies involving 131 492 participants were included. Catheter ablation significantly reduced all‐cause mortality (RR 0.61, 95% CI 0.51–0.71) and cardiovascular mortality (RR 0.46, 95% CI 0.31–0.66), improved LVEF (MD 6.47%, 95% CI 4.47–8.47), and reduced BNP levels (MD −136.85 pg/mL, 95% CI −190.46 to −83.23). No significant reduction was observed in cardiovascular hospitalization (RR 0.78, 95% CI 0.53–1.13). Mortality benefits were consistent across subgroup analyses by study design and baseline LVEF. Conclusions: Catheter ablation was associated with lower mortality and improved cardiac function compared with medical therapy in patients with AF and HFrEF/HFmrEF. Further studies specifically evaluating HFmrEF populations are warranted.

  • Effect of Influenza Vaccination on Major Cardiovascular Events and Mortality: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    by Muhammad Waqar Shahid, Abdullah Hameed, Ayesha Naseem, Fatima Sajjad, Moin Haider Shah, Hamna Khan, Afridi Jahangir Khan, Muhammad Talha Usman, Yasar Ullah, Hiba Abeer, et al.

    Cardiovascular disease remains the leading global cause of mortality despite advances in preventive therapies. Influenza infection is increasingly recognized as a trigger for acute cardiovascular events, prompting interest in influenza vaccination as a potential cardioprotective intervention in high-risk patients. We aimed to conduct a systematic review and meta-analysis to evaluate the effect of influenza vaccination on cardiovascular outcomes in adults with established cardiovascular disease. PubMed, Embase, and Cochrane databases were systematically searched using relevant keywords from inception until October 2025. Seven studies were included after the final screening. Outcomes were reported as all cause mortality, myocardial infarction, major adverse cardiovascular events and heart failure related hospitalization. Interstudy heterogeneity was assessed using I² and X² statistics. Statistical calculations were performed using Review Manager 5.4.1, with a p-value of < 0.05 indicating statistical significance. Seven randomized controlled trials including 12,224 participants were analyzed. Influenza vaccination significantly reduced major adverse cardiovascular events and cardiovascular mortality. A borderline reduction was observed for myocardial infarction and all-cause mortality. No significant differences were found for stroke, coronary revascularization, or heart failure–related hospitalization. Heterogeneity was low for most primary outcomes. The routine use of influenza vaccination as an effective adjunctive strategy in secondary cardiovascular prevention is supported by the fact that it significantly lowers cardiovascular mortality and major cardiovascular events in patients with established heart disease.

  • Open Access

    Efficacy and safety of laparoscopic-guided transversus abdominis plane block versus port-site local anesthetic infiltration in laparoscopic cholecystectomy

    by Javeria Javed, Mahnoor Qasim, Zaryab Bacha, Hunain Shahbaz, Noman Rajput, Fatima Sajjad, Munazza Sikhandar, Ogechukwu Obi, Khushal Khan, Pukar Adhikari, et al.

    Background: Postoperative pain following laparoscopic cholecystectomy remains a major clinical concern, and the optimal method of local anesthetic delivery is unresolved. This systematic review and meta-analysis evaluated the efficacy and safety of laparoscopic-guided transversus abdominis plane (LTAP) block versus port-site local anesthetic infiltration for reducing pain, opioid use, and improving recovery in patients undergoing LC. Methods: This review was conducted per Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines and was prospectively registered on the International Prospective Register of Systematic Reviews (CRD420261344930). PubMed, Embase, and the Cochrane Library were searched from inception to March 2026, without language restriction, for randomized controlled trials (RCTs) comparing LTAP block with standard port-site local anesthetic infiltration in adults undergoing LC. Eligible studies were RCTs reporting at least 1 clinically relevant outcome (postoperative pain, operative time, shoulder pain, rescue analgesia, hospital stay, or discharge within 24 hours); observational studies, non-randomized designs, and reviews were excluded. Risk of bias was assessed independently by 2 reviewers using the Cochrane Risk of Bias 2.0 tool. Data were pooled using a random-effects model (Mantel-Haenszel method with DerSimonian-Laird estimation) in Review Manager version 5.4.1, with heterogeneity quantified using the I-squared statistic (heterogeneity measure). Results: Eight RCTs comprising 711 patients were included (LTAP unilateral in 2 studies, bilateral in 6). LTAP significantly reduced visual analogue scale pain scores at 1, 3, 6, and 24 hours compared with port-site infiltration, although heterogeneity was substantial for some outcomes and was reduced following sensitivity analyses. No significant differences were found between groups in operative time, shoulder pain, rescue analgesia, postoperative nausea and vomiting, or discharge within 24 hours, with a modest reduction in hospital stay favoring LTAP. Grading of Recommendations Assessment, Development and Evaluation certainty of evidence was high for pain at 1 and 3 hours, moderate for most secondary outcomes, and low for pain at 6 and 12 hours. Trial sequential analysis confirmed the reliability of the benefit for early pain relief and hospital stay, while several outcomes remained inconclusive. Conclusion: LTAP block provides superior early postoperative analgesia compared with port-site local anesthetic infiltration after laparoscopic cholecystectomy, with a modest reduction in hospital stay, although evidence for several secondary outcomes remains limited by heterogeneity and inconclusive trial sequential analysis.

  • Efficacy and safety of tranexamic acid in patients undergoing hip hemiarthroplasty: an updated systematic review and meta-analysis

    by Umama Alam, Muhammad Asad Asif, F. N. U. Mainka, Iftikhar Khan, Zonaira Mushahid, Talha Bin Tariq, Muhammad Ansab, Fatima Sajjad, Mohammad Ahmer Minhaj, Ibadullah Tahir, et al.

    Hip hemiarthroplasty for femoral neck fractures is often associated with substantial perioperative blood loss and transfusion requirements. Tranexamic acid (TXA) may reduce bleeding, but concerns remain regarding thromboembolic safety. This systematic review and meta-analysis evaluated the efficacy and safety of TXA in hip hemiarthroplasty. PubMed, Embase, and Cochrane were searched from inception to February 2026. Randomized controlled trials and cohort studies comparing TXA with no TXA or no TXA in patients undergoing hip hemiarthroplasty were included. Random-effects meta-analyses were performed to pool risk ratios (RRs) and mean differences (MDs), with subgroup and sensitivity analyses conducted to assess the robustness of the findings. The primary outcome was total blood loss. Secondary outcomes included postoperative haemoglobin, transfusion requirement, mortality, thromboembolic events, surgical site infection, stroke MI and length of hospital stay. Although total blood loss was the pre-specified primary outcome, transfusion requirement was also evaluated as an important secondary outcome because of its direct clinical relevance. Fourteen studies comprising 7,660 patients (3,271 TXA and 4,389 controls) were included. TXA significantly reduced allogeneic transfusion requirements (RR 0.48, 95% CI 0.38–0.61; P<0.001) and improved postoperative day-1 haemoglobin (MD 0.48 g/dL, 95% CI 0.14–0.83; P=0.011). A reduction in 30-day mortality (RR 0.69, 95% CI 0.49–0.96; P=0.029) and length of hospital stay (MD −1.57 days, 95% CI −3.12 to −0.03; P=0.047) was observed, although both findings were sensitive to individual studies and should be interpreted cautiously. Total blood loss was not significantly different between groups (MD −162.73 mL, 95% CI −346.49 to 21.02; P=0.076) because of extreme heterogeneity. TXA was not associated with an increased risk of DVT, PE, MI, stroke, or surgical site infection. No significant differences were observed between intravenous and intra-articular administration. TXA is an effective and safe adjunct in patients undergoing hip hemiarthroplasty. It significantly reduces transfusion requirements and preserves early postoperative haemoglobin without increasing major postoperative complications. Although reductions in 30-day mortality and length of hospital stay were observed, these findings require cautious interpretation because they were less robust and largely derived from observational evidence. Further high-quality randomized controlled trials are warranted to confirm these potential benefits.

  • Open Access

    Bartter Syndrome With Normal Aldosterone Level and Acute Pancreatitis: An Unusual Presentation

    by Noor Ayaz, Matti Ullah, Waqar Ahmad, Farhan Ullah, Ikram Ullah Khan, Fahad Naim, Awais Naeem, Fatima Sajjad, Kamil Ahmad Kamil

    Bartter syndrome is a rare autosomal recessive renal tubulopathy, which classically presents with hypokalemic metabolic alkalosis, hyperreninemia, and hyperaldosteronism. We report an atypical presentation in a 16‐year‐old male who was diagnosed following an initial manifestation of acute pancreatitis. Key biochemical findings included profound hypokalemia (1.4 mEq/L), metabolic alkalosis, hyperreninemia (218.5 uIU/mL), and hypercalciuria, yet with a normal serum aldosterone level, which is a notable deviation from the classic biochemical profile. The acute pancreatitis was attributed to severe hypokalemia‐induced pancreatic ductal dysfunction. This case underscores that a normal aldosterone level does not exclude Bartter syndrome and emphasizes the importance of considering this possibility in patients with hypokalemic alkalosis and renal salt‐wasting. Furthermore, it highlights severe hypokalemia as a potential, life‐threatening precipitant of acute pancreatitis, warranting prompt investigation in affected patients presenting with acute abdominal pain.